Sanofi India Limited · NSE: SANOFI · BSE: 500674
Sanofi India
Quarterly results as filed with BSE. Latest: Q3 FY25 (Oct–Dec 2024), filed 28 Feb 2025.
Q3 FY25 · Consolidated
Revenue
514.90₹ Cr
−25.8% vs year ago
Net profit
91.30₹ Cr
−33.7% vs year ago
EPS, basic
39.64₹
−33.7% vs year ago
Net margin
17.7%
−2.1 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q3 FY25Oct–Dec 2024 | 514.90 | −25.8% | 91.30 | −33.7% | 39.64 | 28 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 524.00 | −26.7% | 82.19 | −45.9% | 35.69 | 07 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 463.50 | −34.4% | 103.20 | −16.0% | 44.81 | 29 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 732.40 | — | 136.60 | — | 59.31 | 14 May 2024 |
| Q3 FY24Oct–Dec 2023 | 693.90 | — | 137.70 | — | 59.79 | 26 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 714.58 | — | 151.95 | — | 65.95 | 10 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 706.10 | — | 122.90 | — | 53.37 | 16 Aug 2023 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 437.70 | +7.7% | 83.50 | +20.1% | 36.26 | 04 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 472.30 | −11.9% | 102.60 | −14.1% | 44.55 | 28 Apr 2026 |
| Q3 FY26Oct–Dec 2025 | 419.80 | −18.5% | 61.70 | −32.4% | 26.79 | 25 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 475.40 | −9.3% | 76.00 | −7.5% | 32.99 | 29 Oct 2025 |
| Q1 FY26Apr–Jun 2025 | 406.30 | −12.3% | 69.50 | −32.8% | 30.18 | 31 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 535.90 | −26.8% | 119.50 | −12.5% | 51.89 | 14 May 2025 |
| Q3 FY25Oct–Dec 2024 | 514.90 | −25.8% | 91.30 | −33.7% | 39.64 | 28 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 524.00 | −26.7% | 82.19 | −46.0% | 35.69 | 07 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 463.50 | −34.4% | 103.40 | −15.9% | 44.90 | 29 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 732.40 | −0.6% | 136.60 | −28.3% | 59.31 | 14 May 2024 |
| Q3 FY24Oct–Dec 2023 | 693.90 | +3.3% | 137.70 | +5.2% | 59.79 | 26 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 714.58 | +3.3% | 152.14 | +16.2% | 66.08 | 10 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 706.10 | +1.0% | 122.90 | +2.1% | 53.37 | 16 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 736.50 | +4.2% | 190.40 | −20.1% | 82.67 | 12 May 2023 |
| Q3 FY23Oct–Dec 2022 | 671.90 | −2.3% | 130.90 | +44.8% | 56.84 | 27 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 691.90 | −8.3% | 130.90 | −75.3% | 56.84 | 04 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 699.30 | −11.4% | 120.40 | −32.5% | 52.28 | 28 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 707.00 | −2.5% | 238.40 | +63.4% | 103.51 | 27 Apr 2022 |
| Q3 FY22Oct–Dec 2021 | 687.90 | −4.5% | 90.40 | −26.5% | 39.25 | 24 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 754.50 | +9.9% | 529.80 | +298.6% | 230.04 | 27 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 789.10 | +11.1% | 178.30 | +30.8% | 77.42 | 28 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 725.10 | −7.6% | 145.90 | +70.8% | 63.35 | 28 Apr 2021 |
| Q3 FY21Oct–Dec 2020 | 720.30 | −12.8% | 123.00 | +26.4% | 53.41 | 24 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 686.60 | −11.9% | 132.90 | +5.0% | 57.71 | 28 Oct 2020 |
| Q1 FY21Apr–Jun 2020 | 710.50 | −5.0% | 136.30 | +39.9% | 59.18 | 29 Jul 2020 |
| Q4 FY20Jan–Mar 2020 | 784.50 | +9.4% | 85.40 | −8.1% | 37.08 | 20 May 2020 |
| Q3 FY20Oct–Dec 2019 | 826.30 | +13.8% | 97.30 | +22.7% | 42.26 | 26 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 779.10 | +4.7% | 126.60 | +6.2% | 54.96 | 13 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 747.90 | +9.4% | 97.40 | −2.2% | 42.29 | 30 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 717.30 | — | 92.90 | — | 40.34 | 08 May 2019 |
| Q3 FY19Oct–Dec 2018 | 726.40 | — | 79.30 | — | 34.48 | 27 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 743.80 | — | 119.20 | — | 51.83 | 01 Nov 2018 |
| Q1 FY19Apr–Jun 2018 | 683.60 | — | 99.60 | — | 43.30 | 26 Jul 2018 |
40 filings on record for this company.